The White House Put US Science On A Leash, And Called It ‘Budget Process’

The newsroom coffee tastes like burnt wiring, and my phone keeps buzzing like a committee-room microphone with a loose ground. Outside, the city is wet neon and brake lights. Inside, it is spreadsheets. The kind that can quietly kill a lab without ever raising a hand in public.

Because the White House Office of Management and Budget is reportedly slowing the release of already approved federal science money, leaving NIH in particular unable to spend research funding that Congress wrote into law and the President signed. Translation: you can pass the bill, sign the bill, and still choke the bloodstream.

OMB slows the release of science funding already signed into law

Nature reported on February 27, 2026 that OMB has been slow to authorize the flow of fiscal year 2026 funds to major research agencies. The article describes NIH as not having received approval to spend any of the research funding allocated in a budget bill signed into law on February 3, 2026, while NSF only got authorization to spend its funds last week. NASA, meanwhile, reportedly received full funding authorization, but with an unusual restriction limiting spending on ten specific programs until it provides more detail on how the money will be used.

This is not a harmless paperwork hiccup. Grant cycles run on calendars. Peer review panels are booked. Postdocs have leases. Patients are waiting on trials. Universities keep labs running like 24-hour factories for knowledge, except the raw material is time and the supply chain is federal money.

And when you delay the money, you delay the science. The delay is the decision.

Translation: “apportionment” is a throttle

Translation: apportionment is the part of the budget process where OMB decides how much of an agency’s money it can actually use, and when. It is supposed to prevent agencies from blowing through funds too quickly. It is not supposed to let the executive branch rewrite what Congress funded after the vote is over.

Nature described a change to OMB guidance that restricted the automatic 30-day funding portions agencies usually receive after a full-year budget is enacted, limiting them to essential expenses like salaries until OMB approves spending plans. That sounds like a sleepy footnote until you look at the output: fewer awards, fewer new projects, more stalled work.

Here is the mechanism: hollow out science without a public fight

Here is the mechanism: Congress appropriates. The President signs. Agencies plan. Then OMB slows the release, and agencies cannot obligate money on the normal cadence. That delay ripples outward.

Universities do not stop paying electricity to keep freezers running. They do not stop paying compliance staff. Those costs get shifted. Labs burn through bridge funding. Some institutions can float it. Many cannot. Early-career scientists get squeezed like paper cups.

Follow the money: power shifts to whoever can write checks on time

Follow the money: when federal research slows, the private sector does not suddenly become generous. It becomes more powerful. If NIH cannot reliably fund work, universities and labs chase alternatives: corporate partnerships, defense dollars, philanthropic megadonors with pet theories. The kind of funding that comes with strings and steering committees that look like boardroom glass.

The White House can call it “reviewing spending plans.” But the output is the point. If NIH cannot spend, it cannot award. If it cannot award, fewer labs can hire. Then the public pays twice: once in taxes that do not become research, and again in delayed treatments, weaker preparedness, and lost capacity.

The quiet part: discipline the institutions that produce inconvenient facts

The quiet part: universities and federal science agencies still produce inconvenient facts at scale. Facts about pollution. Facts about climate impacts. Facts about public health. If you want a country where policy is written by donors and PR, you do not have to ban science outright. You just make it slow, precarious, and dependent on executive permission slips.

So drag this into the light: oversight hearings with documents, not vibes. Inspector General audits. GAO reviews. Court challenges if lawful appropriations are being functionally impounded. We passed the money. We signed the money. Now who decided science had to beg for permission to use it?